More than 200 mushrooms—primarily those belonging to a genus of gilled mushrooms called Psilocybe—contain the psychoactive compound psilocybin. In the brain of mammals, this chemical can bind to serotonin receptors and influence ...
13 hours ago
0
8
Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body's defense systems, according to a study led by investigators at Weill Cornell Medicine. The discovery ...
Apr 30, 2026
0
8
Researchers at the Champalimaud Foundation in Lisbon have for the first time managed to identify with an imaging technique whether nervous impulses in the brain of rats are flowing in a "bottom-up" (feedforward), carrying ...
May 4, 2026
0
8
Spring's warmer weather lures people outdoors—and into possible contact with ticks that spread Lyme disease.
May 1, 2026
0
7
Lithium chloride may affect many cellular level changes in Alzheimer's disease, a new study from the University of Eastern Finland (UEF) shows. The work is published in the journal Biomedicine & Pharmacotherapy.
21 hours ago
0
7
A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy drinking days in the past 30 days by an average of roughly 12 days, 50% higher than the eight-day ...
Apr 30, 2026
0
7
The core facilities of the Cibio Department of the University of Trento have all taken part in a study on amyotrophic lateral sclerosis (ALS) to better understand the molecular mechanisms of slow-progressing cases. The study ...
May 5, 2026
0
7
A new perspective published in JAMA challenges the growing narrative that artificial intelligence (AI) is poised to replace physicians, arguing instead that the technology exposes deeper structural failures in modern health ...
Apr 30, 2026
0
7
Attractiveness of the nose affects how people view the face—with attractive noses actually drawing less attention than unattractive noses, reports a study in the May issue of Plastic and Reconstructive Surgery.
May 1, 2026
0
7
Chronic neuropathic pain remains one of the most challenging conditions to treat, with current therapies offering limited benefit and being over-reliant on opioids. Researchers at Rensselaer Polytechnic Institute (RPI), along ...
May 6, 2026
0
7
